wells-fargo-banner
2019 Wells Fargo Healthcare Conference
September 4 - 5, 2019, Westin Copley Place , Boston, Massachusetts
Conference Coordinator: Deirdre Gilfeather
2019 Wells Fargo Healthcare Conference
September 4 - 5, 2019, Westin Copley Place , Boston, Massachusetts
Conference Coordinator: Deirdre Gilfeather
Wells Fargo Securities Research, Economics & Strategy


2019 Wells Fargo Healthcare Conference


Please join us September 4-5 for the 14th Annual Wells Fargo Securities Healthcare Conference in Boston.

The conference will consist of select company presentations and customized one-on-one meetings with senior executives from leading Healthcare Companies.

Please review the information below as you prepare for the conference and contact us with any questions.

 
Agenda

Please scroll down for a detailed agenda.

Wednesday, September 4

7:00 a.m.
Breakfast and registration - Essex Ballroom Foyer, 3rd Floor

8:00 a.m. - 5:00 p.m.
Company Presentations / Fireside Chats, scheduled one-on-ones and group meetings

12:00 p.m.
Keynote Lunch - Dr. Gilbert H. Kliman, Managing Director,  Interwest Partners - Future of Ophthalmology Devices
 
 
Thursday, September 5

7:00 a.m.
Breakfast and registration - Essex Ballroom Royer, 3rd Floor

8:00 a.m. - 5:00 p.m.
Company Presentations / Fireside Chats, scheduled one-on-ones and group meetings
 
12:05 p.m.
Keynote Lunch - Andrew Witty, Office of the Chief Executive, Executive Vice President, UnitedHealth Group, Chief Executive Officer, Optum


Investor one-on-ones


We will be hosting one-on-one meetings in 30 minute slots.  Please submit one-on-one requests when registering online, or contact your Wells Fargo Securities representative.


Participating Companies
* as of August 22
Abbott Laboratories (ABT) - Scott Leinenweber, VP, IR, Licensing & Acquisitions;  Laura Dauer, Director, Investor Relations
Abeona Therapeutics (ABEO) - Jo Siffert, CEO; Christine Silverstein CFO; Sofia Warner, Senior Director, IR
Acadia Healthcare Company, Inc. (ACHC) - Debbie Osteen, CEO; David Duckworth, CFO; Gretchen Hommrich, Director, IR
*  Adaptimmune Therapeutics (ADAP) - Adrian Rawcliffe CFO; Bill Bertrand,COO; Juli Miller, Sr. Director, Investor Relations
*  Affimed (AFMD) - Adi Hoess, CEO; Gregory Gin, Head of IR 
*  Aimmune Therapeutics (AIMT) - Eric Bjerkholt, CFO;  Steve Tilles, Sr. Director, Medical Affairs
 DeDe Sheel, VP, IR 
*  Akcea Therapeutics (AKCA) - Paula Soteropoulos, CEO; Mike MacLean, CFO; Kathleen Gallagher, VP, Corporate Communications & IR; Taylor Larkowski, Investor Relations Associate
*  Akouous, Inc. (Private) - Emmanuel Simons, President & CEO
*  Alcon Inc. (ALC) - David Endicott, CEO; Karen King, SVP, Head Global IR & Communications; Rafael Lopes, Investor Relations
*  Alder Biopharmaceuticals (ALDR) - Carlos Campoy, CFO; Erin Lavelle, COO
*  Allscripts Healthcare Solutions, Inc. (MDRX) - Paul Black, CEO; Stephen Shulstein, VP, IR
*  Amphastar Pharmaceuticals Inc. (AMPH) - Jason Shandell, President; Bill Peters, CFO
*  Anthem, Inc. (ANTM) - John Gallina, EVP & CFO; Chris Rigg, VP, Investor Relations & Corporate Finance; Paige Kerns, Director, IR
*  Applied Genetic Technologies (AGTC) - Sue Washer, President & CEO; Theresa Heah, M.D., M.B.A., Chief Medical Officer; Stephen Potter, Chief Business Officer
*  Arena Pharmaceuticals (ARNA) - Amit Munshi, President & CEO; Kevin Lind, EVP & CFO
*  Ascendis Pharma (ASND) - Jan Mikkelsen, CEO; Scott Smith, CFO; Patti Bank, IR
*  Autolus Therapeutics plc (AUTL) - Christian Itin, CEO; Andrew Oakley, CFO; Susan Noonan, IR
*  Aveta Biomics, Inc. (Private) - Parag Mehta, CEO
*  AVROBIO, Inc. (AVRO) - Geoff MacKay, CEO; Erik Ostrowski, CFO; Chris Mason, CSO
*  Axonics Modulation Technologies Inc. (AXNX) - Raymond W. Cohen, CEO; Dan Dearen, President & CFO
*  Baxter International Inc. (BAX) - Jay Saccaro, EVP & CFO; Clare Trachtman, VP, Investor Relations
*  Becton, Dickinson and Company (BDX) - Tom Polen, President & COO; John Gallagher, SVP, CFO, Medical Segment & Treasurer FP&A; Herman Cueto, SVP & CFO BD Interventional, FP&A; Anthony Di Meo, Sr. Director Investor Relations
*  Bellicum Pharmaceuticals (BLCM) - Richard Fair, President & CEO; Atabak Mokari, CFO
*  BenefitFocus, Inc. (BNFT) - Raymond August, President & CEO; Steve Swad, CFO; Michael Bauer, SR Director Finance & IR
*  BioDelivery Sciences International (BDSI) - Herm Cukier, CEO; Terry Coelho, CFO; Mary Coleman, Vice President, Investor Relations
*  Biohaven Pharmaceutical Holding Co Ltd (BHVN) - Vlad Coric, CEO; Jim Engelhart, CFO
*  Boston Scientific Corporation (BSX) - Michael Mahoney, CEO;   Susan Lisa, Vice President, IR
*  Calithera Biosciences (CALA) - Susan Molineaux, Founder, President & CEO;  Keith Orford, Chief Medical Officer;  Stephanie Wong, SVP of Finance and Secretary; Jennifer McNealey, VP of Investor Relations and Strategy
*  Cellectis SA (CLLS) - Andr?Choulika, Chairman & CEO;  Simon Harnest, Vice President, Corporate Strategy & Finance
*  Celyad (CYAD) - Filippo Petti, CEO; Anne Moore, VP, Strategy
*  Centene Corporation (CNC) - Ed Kroll, SVP, Finance and IR Erica Silver, Director, IR
*  Cerner Corporation (CERN) - Marc Naughton, EVP & CFO; Allan Kells, SVP, IR
*  CIGNA Corp. (CI) - Eric Palmer, EVP & CFO; William McDowell, Vice President, Investor Relations; Frederick Manning, Investor Relations
*  Clovis Oncology, Inc. (CLVS) - Patrick Mahaffy, President & CEO; Breanna Burkart, VP, IR & Corporate Communications
*  Computer Programs & Systems Inc. (CPSI) - Matt Chambless, CFO
*  Conformis Inc. (CFMS) - Mark Augusti, President & CEO; Paul Weiner, CFO
*  Cooper Companies, Inc. (COO) - Al White, President & CEO
*  CRISPR Therapeutics (CRSP) - Susie Kim, VP, Corporate Communications & IR; Claudia Styslinger, Investor Relations
*  CymaBay Therapeutics (CBAY) - Sujal Shah, President and CEO; Janet Dorling, CCO
*  Edwards Lifesciences Corporation (EW) - Mike Mussallem, Chairman & CEO; Scott Ullem, Corporate VP & CFO; Todd Brinton, Corporate VP, Advanced Technology & Chief Scientific Officer;  Mark Wilterding, VP of IR
*  Ellex (ELXMF)
*  Emergent BioSolutions Inc. (EBS) -
Robert Kramer, President and CEO; Richard Lindahl, EVP, CFO
*  Encompass Health (EHC) - Mark Tarr, President & CEO; Doug Coltharp, EVP & CFO; Crissy Carlisle, Chief Investor Relations Officer
*  Evofem Biosciences (EVFM) - Saundra Pelletier, CEO; Russ Barrans, Chief Commercial Officer; Kelly Culwell, Chief Medical Officer; Amy Raskopf, Head of Investor Relations
*  Evolent Health (EVH) - Frank William, CEO; John Johnson, CFO; Nicky McGrane, EVP, Corporate Performance
*  Evolus Inc. (EOLS) - David Moatazedi, President & Chief Executive Office; Lauren Silvernail, CFO & EVP, Corporate Development; Ashwin Agarwal, VP Finance, IR & Treasury; Kaitlyn Brosco, Investor Relations; Tram Bui, Investor Relations
*  Fate Therapeutics, Inc. (FATE) - Scott Wolchko, CEO; Dan Shoemaker, CSO
*  Five Prime Therapeutics (FPRX) - Aron Knickerbocker, CEO; Helen Collins, CMO; Martin Forrest, VP, Investor Relation & Corp Comm
*  Flexion Therapeutics, Inc. (FLXN) - Michael Clayman, CEO; David Arkowitz, CFO; Scott Young, SVP of Corporate
*  Glaukos Corporation (GKOS) - Joe Gilliam, CFO;  Chris Calcaterra, COO;  Chris Lewis, IR
*  Globus Medical, Inc. (GMED) - Dan Scavilla, EVP & CCO; Keith Pfeil, SVP & CFO; Brian Kearns, Sr. VP Business Development
*  Halozyme Therapeutics (HALO) - Helen Torley, CEO; Albert Kildani, Investor Relations
*  Hanger Inc. (HNGR) - Vinit Asar, President & CEO; Tom Kiraly, EVP & CFO; Seth Frank, VP Treasury & Investor Relations
*  HCA Healthcare Inc. (HCA) - Bill Rutherford, EVP & CFO; Mark Kimbrough, VP, Investor Relations
*  HealthEquity, Inc. (HQY) - Jon Kessler, President & CEO; Darcy Mott, EVP & CFO; Tyson Murdock, SVP & Controller; Richard Putnam, IR
*  HMS Holdings Corporation (HMSY) - Jeff Sherman, CFO; Robert Borchert, Investor Relations
*  Hookipa Pharma (HOOK) - Joern Aldag, CEO; Igor Matushansky, MD, PhD, CMO; Matt Beck, Executive Director, IR;  Susan Noonan, IR
*  Humana Inc. (HUM) - Bruce Broussard, CEO; Lisa Stoner, Director, Investor Relations
*  Immunomedics, Inc. (IMMU) - Behzad Aghazadeh, Executive Chairman; Usama Malik, CFO & Chief Business Officer; Chau Cheng, Sr. Director, IR
*  Impulse Dynamics (Private) - Simos Kedikoglou, CEO; Gerald Haines, CFO
*  IMV, Inc. (IMV) - Frederic Ors, CEO; Pierre Labbe, CFO
*  Infinity Pharmaceuticals (INFI) - Lawrence Bloch, President; Adelene Perkins, Chairman & CEO; Jeff Kutok, Chief Scientific Officer
*  Inspire Medical Systems, Inc. (INSP) - Tim Herbert, President & CEO; Rick Buchholz, CFO
*  Integra LifeSciences Holdings Corporation (IART) - Carrie Anderson, CFO; Glenn Coleman, Chief Operations Officer; Michael Beaulieu, Director, IR; Sravan Emany, SVP-Strategic Initiatives, Treasury & IR
*  Intuitive Surgical, Inc. (ISRG) - Marshall Mohr, EVP & CFO; Calvin Darling, Sr. Director, IR
*  IONIS Pharmaceuticals, Inc. (IONS) - Beth Hougen, CFO; Damien McDevit, Ph.D, CBO; Wade Walke, Ph.D., VP, Corporate Communications & IR 
*  Iovance Biotherapeutics (IOVA) - Timothy Morris, CFO
*  IRIDEX Corporation (IRIX) - Will Moore, CEO
*  Ironwood Pharmaceuticals, Inc. (IRWD) - Mark Mallon, CEO; Gina Consylman, CFO; Meredith Kaya, VP, Investor Relations and Communications; Garret Bonney, Manager Investor Relations
*  Jazz Pharmaceuticals Plc (JAZZ) - Daniel Swisher, President & COO; Kathrine Littrell, VP, IR
*  Johnson & Johnson (JNJ) - Ashley McEvoy, EVP, Worldwide Chairman, Medical Devices; Jon Pais, Senior Manager; Chris DelOrefice, VP, Investor Relations; Matt Stuckley, Sr. Director, IR
*  Jounce Therapeutics (JNCE) - Richard Murray, Ph.D., CEO & President; Kim Drapkin, CFOElizabeth Trehu, MD, CMO; Komal Joshi, Investor Relations & Strategic Finance
*  Kala Pharmaceuticals, Inc. (KALA) - Mark Iwicki, Chairman & CEO; Mary Reumuth, CFO; Todd Bazemore, COO; Niranjan Kameswaran, VP, Strategy
*  Karuna Therapeutics Inc. (KRTX) - Steve Paul, CEO; Troy Ignelzi, CFO; Jason Brown, VP, Finance
*  Kezar Life Sciences (KZR) - John Fowler, CEO;  Christopher Kirk, CSO; Celia Economides, SVP, Strategy and External Affairs
*  Lantheus Holdings, Inc. (LNTH)- Mary Anne Heino, President & CEO; Robert Marshall, CFO & Treasurer; Mark Kinarney, Director, IR
*  LeMaitre Vascular Inc. (LMAT) - JJ Pellegrino, CFO
*  Lexicon Pharmaceuticals, Inc. (LXRX) - Jeff Wade, EVP & CFO; Pablo Lapuerta, EVP, Chief Medical Officer; Kim Lee, Exec. Director, Investor Relations & Strategy
*  Mallinckrodt Plc (MNK) - Mark Trudeau, President & CEO; Bryan Reasons, EVP & CFO; Steve Romano, M.D., EVP & Chief Scientific Officer; Daniel Speciale, VP, Investor Relations and IRO
*  MAXIMUS, Inc. (MMS) - Bruce Caswell, CEO; Matthew Burns, Investor Relations Manager
*  MediWound Ltd. (MDWD) - Sharon Malka, CEO
*  Medtronic plc (MDT) - Michael Coyle, EVP & President, Cardiac & Vascular Group; Ryan Weispfenning, VP IR; Wynne Edgson, Director, IR
*  MEI Pharma (MEIP) - Dan Gold, Ph.D, CEO;  David Walsey, VP
*  Merit Medical Systems (MMSI)
*  Moderna Therapeutics (MRNA)
*  Momenta Pharmaceuticals, Inc. (MNTA)
-  Craig Wheeler, CEO; Michelle Robertson,CFO; Young Kwon, Chief Business Officer; Patty Eisenhaur, VP, Investor Relations
*  Morphic Holding, Inc. (MORF) - Praveen Tipirneni, President & CEO
*  Mustang Bio, Inc. (MBIO) - Manny Litchman, President & CEO
*  MyoKardia, Inc. (MYOK) - Taylor Harris, CFO; Bill Fairey, Chief Commercial Officer
Marc Semigran, SVP, Medical Sciences; Michelle Corral, Head of IR and Corporate Communications
*  Natus Medical Inc. (NTUS) - Drew Davies, CFO
*  Neos Therapeutics, Inc. (NEOS) - Jerry McLaughlin, CEO and Director; Richard Eisenstadt, CFO
*  Novartis AG (NVS) - Troy Dale, Global Head Strategic Partnerships Team
*  NovoCure Limited (NVCR) -
Wilco Groenhuysen, CFO; Ashley Cordova, SVP, Finance and IR; Gabrielle Fernandes, Associate Director, IR
*  NuVasive Inc (NUVA) - Chris Barry, CEO; Suzanne Hatcher, Vice President, Internal & External Affairs
*  Ocular Therapeutix Inc (OCUL) - Antony Mattessich, CEO; Donald Notman, CFO
*  Omnicell, Inc. (OMCL) - Randall Lipps, Chairman, President, CEO &  Founder; Peter Kuipers, EVP, CFO; Jamie Conroy, VP and Corporate Treasurer; Joe Colone, Assistant Treasurer
*  OMNIlife Science (Private) - Rick Epstein, CEO
*  Opiant Pharma (OPNT) - Roger Crystal, M.D., CEO; David O?oole, CFO; Lisa Sher, Senior Director, IR and Communications
*  Osmotica Pharmaceuticals plc. (OSMT) - Brian Markison, CEO; Andrew Einhorn, CFO
*  Oxford Immunotec Global PLC (OXFD) - Peter Wrighton-Smith, CEO; Matt McLaughlin, CFO
*  Penumbra, Inc. (PEN) - Adam Elsesser,President & CEO; Sri Kosaraju, CFO & Head of Strategy; Jee Hamlyn-Harris, Investor Relations
*  Precision Biosciences (DTIL) - Matt Kane, CEO
*  Premier, Inc. (PINC) - Adam Elsesser,President & CEO; Sri Kosaraju, CFO & Head of Strategy; Jee Hamlyn-Harris, Investor Relations
*  Principia Biopharma Inc. (PRNB) - Martin Babler, CEO; Christopher Chai, CFO; Alex Sharif, Director, IR and Business Development
*  Regulus Therapeutics (RGLS) - Joseph Hagan, CEO; Daniel Chevallard, CFO
*  Relay Therapeutics (Private) - Sanjiv Patel, President & CEO; Imogen Pryce, VP, Strategy & Corporate Affairs; Jim Watters, SVP, Biology; Dan Bergstrom, Head of R&D
*  Revance Therapeutics, Inc. (RVNC) - Dan Browne, President & CEO; Jeanie Herbert, IRO
*  Rodin Therapeutics (Private) - Adam Rosenberg, CEO; Ajim Tamboli CFO
*  RxSight (Private) - Ronald Kurtz, President and Chief Executive Officer
*  Sangamo Therapeutics (SGMO)
*  SeaSpine Holdings Corp (SPNE)
- Keith Valentine, CEO; John Bostjancic, CFO
*  Second Sight Medical (EYES) - Will McGuire, CEO; John Blake, CFO
*  Select Medical Holdings Corporation (SEM) -
Martin Jackson, CFO; Robert Ortenzio, Executive Chairman
*  Service Corp International (SCI) - Aaron Foley, Vice President and Treasurer; Debbie Young, Director of Investor Relations
*  Shockwave Medical Inc (SWAV) - Doug Godshall, CEO; Debbie Kaster, Investor Relations
*  Sientra, Inc. (SIEN) - Paul Little, CFO
*  SIGA Technologies, Inc. (SIGA) - Phil Gomez, PH.D, CEO; Dan Luckshire, CFO; Robin Abrams, General Counsel & CAO; Marianna Anesti, VP, Business Development & Corporate Strategy
*  Silence Therapeutics (SLN) - David Solomon, CEO; Rob Quinn, CFO; Peter Vozzo, IR
*  Sunesis Pharmaceuticals (SNSS) - Dayton Misfeldt, CEO; William Quinn, CFO
*  Supernus Pharmaceuticals Inc. (SUPN) - Jack Khattar, CEO; Greg Patrick CFO; Peter Vozzo, IR
*  Tabula Rasa HealthCare Inc. (TRHC) - Brian Adams, CFO;  Andrea Speers, CAO
*  Teladoc, Inc. (TDOC) - Jason Gorevic, CEO; Mala Murthy, CFO
*  Teleflex, Inc. (TFX) - Liam Kelly, CEO; Jake Elguicze, Treasurer and Vice President, Investor Relations
*  Tenet Healthcare (THC) - Brendan Strong, VP, Investor Relations
*  Theravance Biopharma (TBPH) - Rick Winningham, Chairman & CEO; Andrew Hindman, SVP & CFO; Brett Haumann, SVP, Clinical Development & CMO; Jessica Stitt, VP, Finance and Investor Relations
*  Titan Medical (TMD) - David McNally, President & CEO; Charles Federico, Chairman
Stephen Randall, CFO; Chad Zaring, Chief Commercial Officer
*  TRACON Pharmaceuticals, Inc. (TCON) - Charles Theuer, President & CEO; Scott Brown, Vice President, Finance
*  TransEnterix (TRXC) - Todd Pope, President & CEO; Joe Slattery, EVP & CFO
*  Triple-S Management (GTS) - Roberto Garcia-Rodriguez, CEO; Juan Jose Roman-Jimenez, CFO
*  Turning Point Therapeutics (TPTX) - Athena Countouriotis, CEO;  Jim Mazzola, SVP
*  UDG Healthcare plc (UDG) - Keith Byrne, SVP, Strategy & IR;  Liam Logue, EVP, Corporate Development;  Luke Ferriter, IR Manager
*  uniQure NV (QURE) - Matthew Kapusta, CEO; Sander van Deventer, Chief Scientific Officer;  Maria Cantor, SVP, Investor Relations & Communications
*  UnitedHealth Group (UNH) - Andrew Witty, Office of the Chief Executive, EVP, UnitedHealth Group, Chief Executive Officer, Optum; John Rex, Executive Vice President and CFO; Brian Thompson, CEO, UnitedHealthcare Government Programs; Brett Manderfeld, SVP, Investor Relations
*  Universal Health Services (UHS) - Steve Filton, CFO
*  Veracyte (VCYT) - Bonnie Anderson, Chairman & CEO; Angie McCabe, VP, IR & Corporate Communications
*  Vocera Communications, Inc. (VCRA) - Justin Spencer, CFO; Sue Dooley, VP, Investor Relations
*  Voyager Therapeutics, Inc. (VYGR) - Andre Turenne, CEO;  Allison Dorval, CFO; Omar Khwaja, CMO
*  Wright Medical Group N.V. (WMGI) - Robert Palmisano, President & CEO; Julie Dewey, Sr. VP, Chief Communications Officer
*  Xeris Pharmaceuticals (XERS) - Paul Edick, Chairman and CEO;Lance Berry, Exec VP, CFO & Operations Officer; Allison Wey, SVP, Investor Relations and Corp Comm
*  Zimmer Biomet Holdings Inc. (ZBH) - Cole Lannum, SVP of Investor Relations; Barbara Goslee, Director of Investor Relations
*  Zymeworks Inc. (ZYME) - Ali Tehrani, President & CEO;  Neil Klompas, CFO

Registration

Register to attend by Friday, August 30

To register for this event click on the Registration tab

Reserve your hotel room by August 15

Hotel Location
The Westin Copley Place
10 Huntington Ave.
Boston, MA 02115
617-262-9600


Rate: $319 per night on a space available basis. Please call 617-262-9600 and reference the Wells Fargo Healthcare Conference when making your reservation.

Please note the Westin Copley Place block is full on select dates.  Please click here for some suggested nearby hotels

Key dates

August 2:
One-on-one requests due

August 9:
Companies to receive one-on-one schedules

August 16:
Investors to receive one-on-one schedules

 

Contact information

General inquiries
Deirdre Gilfeather
646-648-3945


deirdre.m.gilfeather
@wellsfargo.com


2019 Healthcare Conference | Agenda

September 4, 2019

Wednesday, September 4

Essex Ballroom South, 3rd Floor

Staffordshire,

3rd Floor

Essex Ballroom Center, 3rd Floor

Essex Ballroom North, 3rd Fl.

St. George AB, 3rd Floor

St. George CD, 3rd Floor

7:00 am

7:45 am

Registration·Essex Ballroom Foyer, 3rd Floor / Breakfast ·American Ballroom Foyer, 4th Floor

7:45 am

8:25 am

Economic Outlook ·Sarah House, Senior Economist, Wells Fargo Securities ·American Ballroom, 4th Floor

8:30 am

9:00 am

Cerner Corporation (CERN)

Intuitive Surgical, Inc. (ISRG)

Jazz Pharmaceuticals plc (JAZZ)*

Arena Pharmaceuticals (ARNA)

Zymeworks Inc. (ZYME)

Aimmune Therapeutics (AIMT)*

 

9:05 am

 

9:35 am

Centene Corporation
(CNC)*

Edwards Lifesciences Corporation (EW)*

MediWound Ltd. (MDWD)

Affimed (AFMD)*

Adaptimmune Therapeutics (ADAP)*

UDG Healthcare plc (UDG)

 

9:40 am

 

10:10 am

Humana Inc. (HUM)*

Teleflex, Inc.(TFX)*

Flexion Therapeutics, Inc. (FLXN)*

Moderna Therapeutics (MRNA)

Voyager Therapeutics, Inc. (VYGR)*

Silence Therapeutics
 (SLN)*

 

10:15 am

 

10:45 am

Acadia Healthcare Company, Inc. (ACHC)

Abbott Laboratories (ABT)

Evolus Inc

(EOLS)*

Akcea Therapeutics (AKCA)*

Turning Point Therapeutics
(TPTX)*

Impulse Dynamics (Private)

 
 
10:50 am

 
  11:20 am

Evolent Health (EVH)*

Globus Medical, Inc. (GMED)

 

Halozyme Therapeutics (HALO)

Sunesis Pharmaceuticals (SNSS)*

 Rodin Therapeutics (Private)

11:25 am

11:55 am

HealthEquity, Inc.(HQY)*

Becton, Dickinson and Company
(BDX)*

Momenta Pharmaceuticals, Inc. (MNTA)*

MEI Pharma

(MEIP)

Aveta Biomics, Inc. (Private) 

 Akouos, Inc (Private)

12:00 pm

1:10 pm

Lunch and Keynote Session ·American Ballroom, 4th Floor
Dr. Gilbert H. Kliman, Managing Director, InterWest Partners - Future of Ophthalmology Devices

1:15 pm

1:45 pm

Triple-S Management
(GTS)*

NovoCure Limited (NVCR)*

Revance Therapeutics, Inc. (RVNC)*

Theravance Biopharma (TBPH)*

Immunomedics, Inc. (IMMU)*

RxSight, Inc. (Private)

 

1:50 pm

 

2:20 pm

Select Medical Holdings Corporation (SEM)

Merit Medical System (MMSI)

NuVasive Inc. (NUVA)*

Emergent BioSolutions Inc. (EBS)

Calithera Biosciences (CALA)*

Infinity Pharmaceuticals (INFI)

 

2:25 pm

 

2:55 pm

BenefitFocus, Inc. (BNFT)

Shockwave Medical Inc. (SWAV)

LeMaitre Vascular Inc. (LMAT)

Ironwood Pharmaceuticals, Inc. (IRWD)*

Ascendis Pharma (ASND)*

Alder Biopharmaceuticals  
(ALDR)*

 

3:00 pm

 

3:30 pm

ConforMIS, Inc.

(CFMS)

Penumbra, Inc.(PEN)*

Second Sight Medical (EYES)*

Evofem Biosciences (EVFM)

Autolus Therapeutics plc (AUTL)*

IMV, Inc. (IMV)*

3:35 pm

4:05 pm

Titan Medical

(TMD)*

Glaukos Corporation (GKOS)*

 

Karuna Therapeutics Inc. (KRTX)

Bellicum Pharmaceuticals (BLCM)*

CymaBay Therapeutics (CBAY)*

4:10 pm

4:40 pm

Omnicell, Inc. (OMCL)*

Inspire Medical Systems, Inc. (INSP)*

Iridex Corporation(IRIX)

 Relay Therapeutics

Hookipa Pharma (HOOK)*

Celyad (CYAD)

 All Day

One-on-one company meetings

*Webcasting Company

September 5, 2019

 

Thursday, September 5

Essex Ballroom South, 3rd Floor

Staffordshire,

3rd Floor

Essex Ballroom Center, 3rd Floor

Essex Ballroom North, 3rd Fl.

St. George AB, 3rd Floor

St. George CD, 3rd Floor

7:00 am

8:00 am

Registration·Essex Ballroom Foyer, 3rd Floor / Breakfast ·American Ballroom Foyer, 4th Floor

8:00 am

8:30 am

CIGNA Corp.

 (CI)*

Medtronic plc (MDT)*

HMS Holdings Corporation (HMSY)

Kala Pharmaceuticals, Inc. (KALA)*

AVROBIO, Inc. (AVRO)

 

8:35 am

9:05 am

Encompass Health (EHC)*

Boston Scientific Corporation (BSX)*

Teladoc, Inc. (TDOC)

Clovis Oncology, Inc. (CLVS)*

IOVANCE Biotherapeutics, Inc. (IOVA)

Fate Therapeutics, Inc. (FATE)

9:10 am

9:40 am

Anthem,
Inc.

(ANTM)*

Wright Medical Group N.V. (WMGI)*

 

Mallinckrodt Plc (MNK)*

Five Prime Therapeutics
(FPRX)*

Veracyte

(VCYT)

9:45 am

10:15 am

Universal Health Services Inc.
(UHS)*

Johnson & Johnson (JNJ)*

Allscripts Healthcare Solutions, Inc. (MDRX)*

Neos Therapeutics, Inc. (NEOS)*

Ionis Pharmaceuticals, Inc. (IONS)*

Kezar Life Sciences (KZR)

10:20 am

10:50 am

HCA Healthcare Inc. (HCA)*

The Cooper Companies, Inc. (COO)*

TransEnterix, Inc.(TRXC)*

Opiant Pharma (OPNT)*

Mustang Bio (MBIO)

uniQure NV

(QURE)

10:55 am

11:25 am

Service Corp International (SCI)

Alcon Inc.

(ALC)*

MAXIMUS, Inc. (MMS)

BioDelivery Sciences International (BDSI)*

Sangamo Therapeutics (SGMO)

OMNIlife science (Private)

11:30 am

12:00 pm

 Lantheus Holdings, Inc. (LNTH)*

Zimmer Biomet Holdings Inc. (ZBH)*

 

Xeris Pharmaceuticals (XERS)

Cellectis SA (CLLS)

Osmotica Pharmaceuticals plc. (OSMT)*

12:05 pm

1:15 pm

Lunch and Keynote Session ·American Ballroom, 4th Floor

Andrew Witty, Office of the Chief Executive, Executive Vice President, UnitedHealth Group, CEO, Optum

1:20 pm

1:50 pm

Tabula Rasa HealthCare Inc.(TRHC)

Baxter International Inc. (BAX)*

SeaSpine Holdings Corp (SPNE)

Supernus Pharmaceuticals Inc. (SUPN)*

Jounce Therapeutics (JNCE)

Precision Biosciences (Private)

 

1:55 pm

 

2:25 pm

Natus Medical Incorporated (NTUS)*

Integra LifeSciences Holdings Corporation (IART)*

Ellex (ELXMF)

Biohaven Pharmaceutical Holding Co Ltd (BHVN)

MyoKardia, Inc. (MYOK)

TRACON Pharmaceuticals, Inc. (TCON) 

2:30 pm

3:00 pm

 

Axonics Modulation Technologies Inc. (AXNX)*

Ocular Therapeutix Inc. (OCUL)

Lexicon Pharmaceuticals, Inc. (LXRX)*

 

Abeona Therapeutics (ABEO)

3:05 pm

3:35 pm

 

 

 

Amphastar Pharmaceuticals Inc. (AMPH)*

Applied Genetic Technologies (AGTC)

Morphic Holding, Inc. (MORF)

3:40 pm

4:10 pm

 

 

 

SIGA Technologies, Inc. (SIGA)*

Principia Biophar*ma Inc. (PRNB)*

Regulus Therapeutics (RGLS)

 All Day

One-on-one company meetings

*Webcasting Company

 

Companies Participating in one-on-one meetings only

 

Computer Programs & Systems Inc. (CPSI)

CRISPR Therapeutics (CRSP)

Hanger Inc. (HNGR)

Novartis AG (NVS)

Oxford Immunotec (OXFD)

Premier, Inc. (PINC)

Sientra, Inc. (SIEN)

Tenet Healthcare (THC)

 Vocera Communications, Inc. (VCRA)


Progress